INS and Insulin resistance: The hypoglycemic effect of rh-aFGF135, which had not been previously reported, were evaluated by monitoring the effects on serum glucose levels, oral glucose tolerance test (OGTT), insulin tolerance test (ITT), HOMA-IR for insulin resistance (IR), serum biochemical parameters, and the histopathological changes of organs.